SC
HUMA icon

Shay Capital’s Humacyte HUMA Stock Holding History

Shay Capital’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.1K Sell
69,349
-103,671
-60% -$96.1K ﹤0.01% 469
2026
Q1 		$105K Buy
173,020
+12,120
+8% +$12.6K 0.01% 435
2025
Q4 		$155K Buy
+160,900
New +$228K 0.02% 428
2024
Q2 		– Sell
-59,858
Closed -$186K – 337
2024
Q1 		$186K Sell
59,858
-32,953
-36% -$111K 0.03% 302
2023
Q4 		$264K Buy
92,811
+27,701
+43% +$71.1K 0.05% 187
2023
Q3 		$191K Buy
65,110
+14,874
+30% +$49.2K 0.03% 260
2023
Q2 		$144K Buy
50,236
+30,249
+151% +$109K 0.02% 311
2023
Q1 		$61.8K Sell
19,987
-675
-3% -$1.92K 0.01% 368
2022
Q4 		$43.6K Buy
+20,662
New +$62.7K 0.01% 230

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Shay Capital's HUMA Position: Q2 2026 in Review

Shay Capital reduced its Humacyte (HUMA) stake by 60% in Q2 2026, selling an estimated $96.1K and leaving 69,349 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Shay Capital first reported a position in HUMA in Q4 2022 and has held it in 9 quarters since. The position peaked at $264K in Q4 2023. 162 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Shay Capital held 69,349 shares of Humacyte worth $54.1K as of Q2 2026.
  • Shay Capital sold 103,671 Humacyte shares in Q2 2026, an estimated $96.1K.
  • Humacyte made up ﹤0.01% of Shay Capital's portfolio in Q2 2026, its #469 holding.
  • Shay Capital first reported a position in Humacyte in Q4 2022 and has held it in 9 quarters since.
  • Shay Capital's Humacyte position peaked at $264K in Q4 2023.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.